Auro Laboratories Limited informs you that the Board of Directors at their Meeting held today (i.e. Thursday, November 11, 2021), has transacted the following business:<BR> <BR> Approved the Un-Audited Standalone Financial Results of the Company for the quarter & half year ended on September 30, 2021 as recommended by the Audit Committee.<BR> <BR> Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> ? Un-Audited Standalone Financial Results for the quarter & half year ended September 30, 2021. <BR> ? Statement of Assets and Liabilities as on September 30, 2021. <BR> ? Cash-Flow Statement for the quarter & half year ended September 30, 2021. <BR> ? Limited Review Report received from the Statutory Auditor of the Company.<BR>
|